8-K 1 a92079e8vk.htm FORM 8-K Applied Molecular Evolution, Inc.
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 5, 2003

APPLIED MOLECULAR EVOLUTION, INC.

(Exact name of registrant as specified in its charter)
         
Delaware   000-31101   33-0374014
(State or other jurisdiction
of incorporation)		   (Commission
File Number) 		  (IRS Employer
Identification No.)

3520 Dunhill Street, San Diego, California 92121

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (858) 597-4990

 

ITEM 7 FINANCIAL STATEMENTS AND EXHIBITS.
ITEM 12 DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION
SIGNATURE
INDEX TO EXHIBITS
EXHIBIT 99.1

Table of Contents

ITEM 7 FINANCIAL STATEMENTS AND EXHIBITS.

  (c)   Exhibits.

             
      99.1     Press release of Applied Molecular Evolution, Inc. dated August 5, 2003

ITEM 12 DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION

     On August 5, 2003, Applied Molecular Evolution, Inc. issued an earnings release announcing its financial results for the second quarter ended June 30, 2003. A copy of the earnings release is attached as Exhibit 99.1 to this Form 8-K.

     The information in this Current Report and attached Exhibit are being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Current Report and attached Exhibit shall not be deemed incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

- 2 -

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     Dated: August 5, 2003

         
    APPLIED MOLECULAR EVOLUTION, INC.
         
         
    By                                       /s/ Lawrence E. Bloch
       
        Lawrence E. Bloch, M.D., J.D.
        Chief Financial Officer and Secretary

- 3 -

Table of Contents

INDEX TO EXHIBITS

     
Exhibit    
Number   Exhibit
 
99.1   Press release of Applied Molecular Evolution, Inc. dated August 5, 2003

- 4 -